title: [Role of mTOR inhibition in the treatment of metastatic renal cell carcinoma].
authors.forename: Ryuichi
authors.initials: R
authors.lastname: Mizuno
authors.forename: Akira
authors.initials: A
authors.lastname: Miyajima
authors.forename: Mototsugu
authors.initials: M
authors.lastname: Oya
mesh_terms: D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000556:secondary*; D000068338:Everolimus; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D058990:Molecular Targeted Therapy; D051058:Oncogene Protein v-akt; D019869:Phosphatidylinositol 3-Kinases; D015398:Signal Transduction; D020123:Sirolimus / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D058570:TOR Serine-Threonine Kinases / Q000037:antagonists & inhibitors* / Q000502:physiology
chemical_list: D000068338:Everolimus; D051058:Oncogene Protein v-akt; D019869:Phosphatidylinositol 3-Kinases; D020123:Sirolimus; D058570:TOR Serine-Threonine Kinases; C401859:temsirolimus